Acorn Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$744K Buy
620
+39
+7% +$39.8K 0.18% 118
2026
Q1
$534K Sell
581
-10
-2% -$10.1K 0.16% 129
2025
Q4
$635K Sell
591
-145
-20% -$139K 0.19% 115
2025
Q3
$561K Buy
736
+30
+4% +$22.3K 0.18% 128
2025
Q2
$550K Buy
706
+4
+0.6% +$3.11K 0.2% 107
2025
Q1
$580K Buy
702
+11
+2% +$9.15K 0.24% 92
2024
Q4
$534K Buy
691
+2
+0.3% +$1.66K 0.22% 94
2024
Q3
$610K Buy
689
+117
+20% +$105K 0.26% 79
2024
Q2
$518K Buy
572
+6
+1% +$4.8K 0.26% 80
2024
Q1
$440K Buy
566
+1
+0.2% +$712 0.23% 90
2023
Q4
$330K Hold
565
0.2% 116
2023
Q3
$304K Buy
565
+113
+25% +$58.2K 0.2% 113
2023
Q2
$212K Buy
+452
New +$190K 0.14% 164
2018
Q2
Sell
-42
Closed -$3K 680
2018
Q1
$3K Hold
42
﹤0.01% 685
2017
Q4
$4K Buy
+42
New +$3.57K ﹤0.01% 627

Other funds holding LLY

Acorn Wealth Advisors's LLY Position: Q2 2026 in Review

Acorn Wealth Advisors increased its Eli Lilly (LLY) stake by 6.7% in Q2 2026, buying an estimated $39.8K and bringing the position to 620 shares worth $744K. The position accounts for 0.18% of the portfolio, ranked #118.

Acorn Wealth Advisors first reported a position in LLY in Q4 2017 and has held it in 15 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Acorn Wealth Advisors held 620 shares of Eli Lilly worth $744K as of Q2 2026.
  • Acorn Wealth Advisors bought 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
  • Eli Lilly made up 0.18% of Acorn Wealth Advisors's portfolio in Q2 2026, its #118 holding.
  • Acorn Wealth Advisors first reported a position in Eli Lilly in Q4 2017 and has held it in 15 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Acorn Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.